Brandi Joyner , FNP
Nurse Practitioner - Primary Care • Longview, TX
300 N 3rd St
Longview, TX 756016505
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Brandi Joyner is listed in NPPES under Nurse Practitioner - Primary Care.
-
NPI assigned on September 24, 2021; this date does not establish years in practice.
-
Published CMS data list 4,944 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 195 prescription fills, including refills.
- Gabapentin — 184 prescription fills, including refills.
- Pantoprazole Sodium — 177 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 112 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 95% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 303 clinicians with data). Median for this group: 552. Middle half: 142 to 1,481.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 87 in 2021 to 4,944 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2021–2024.
Practice Location & Contact Primary Location
300 N 3rd St
Longview, TX 756016505
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Brookridge Internal Medicine Associates, Pa; Pallicare, Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2021
What Public CMS Data Show
Nurse Practitioner - Primary Care: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
10,115 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$497,315 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,605.37 across 107 records.
By nature of payment
- Food and Beverage: $2,605.37 across 107 records.
Reporting-company totals (3 largest of 21)
- Bayer Healthcare Pharmaceuticals Inc.: $545.34 across 18 records.
- AstraZeneca Pharmaceuticals LP: $351.11 across 14 records.
- Novo Nordisk Inc: $250.91 across 13 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
5 years (graduated 2021)
CMS Doctors and Clinicians data list 2021 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2021
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Brandi Joyner has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Brandi Joyner as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Longview and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 303 clinicians with data). Median for this group: 552. Middle half: 142 to 1,481.
Too few clinicians listed under Nurse Practitioner - Primary Care in Longview have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 303 clinicians with data). Median for this group: $40,304. Middle half: $2,642 to $146,601.
Too few clinicians listed under Nurse Practitioner - Primary Care in Longview have Medicare Part D data for 2024 to compare.
8 active clinicians are listed under Nurse Practitioner - Primary Care with a practice address in Longview, TX (824 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 5583% from 87 in 2021 to 4,944 in 2024.
- 2021: 87
- 2022: 3,317
- 2023: 5,483
- 2024: 4,944
-
30-day fills
30-day fills increased 7074% from 141 in 2021 to 10,115 in 2024.
- 2021: 141
- 2022: 6,280
- 2023: 11,384
- 2024: 10,115
-
Part D drug cost
Part D drug cost increased 46153% from $1,075 in 2021 to $497,315 in 2024.
- 2021: $1,075
- 2022: $233,191
- 2023: $674,690
- 2024: $497,315
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $657.65 in 2021 to $2,605.37 in 2025.
- 2021: $657.65
- 2022: $2,150.32
- 2023: $2,836.92
- 2024: $3,266.93
- 2025: $2,605.37
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 107 records totaling $2,605.37.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $137.39 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Symbravo | General | $124.63 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
KISUNLA | General | $124.62 |
| Edwards Lifesciences Corporation |
Food and Beverage
In-kind items and services
|
SAPIEN 3 Ultra RESILIA | General | $100.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $95.59 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $82.58 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
— | General | $73.39 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $70.58 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $56.06 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $55.64 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
LOKELMA | General | $53.14 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $50.61 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $29.79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JASCAYD | General | $29.66 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $29.47 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $29.47 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $29.20 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.96 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $28.42 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $26.98 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $24.32 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $22.58 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $22.52 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $21.93 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $21.52 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 195 | 13,608 | $2,152.11 | 69 |
| Gabapentin | Gabapentin | 184 | 10,436 | $3,108.16 | 73 |
| Pantoprazole Sodium | Pantoprazole Sodium | 177 | 13,611 | $1,743.39 | 70 |
| Amlodipine Besylate | Amlodipine Besylate | 174 | 13,466 | $1,023.79 | 66 |
| Losartan Potassium | Losartan Potassium | 146 | 12,250 | $1,258.64 | 60 |
| Montelukast Sodium | Montelukast Sodium | 139 | 10,072 | $1,309.11 | 54 |
| Lisinopril | Lisinopril | 136 | 9,965 | $1,140.74 | 43 |
| Fluticasone Propionate | Fluticasone Propionate | 113 | 5,970 | $1,961.71 | 54 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 107 | 3,613 | $3,614.89 | 49 |
| Duloxetine Hcl | Duloxetine Hcl | 106 | 7,360 | $3,704.93 | 44 |
| Tramadol Hcl | Tramadol Hcl | 103 | 2,737 | $722.81 | 30 |
| Trazodone Hcl | Trazodone Hcl | 95 | 7,570 | $744.88 | 47 |
| Levothyroxine Sodium | Levothyroxine Sodium | 89 | 6,960 | $986.74 | 35 |
| Pregabalin | Pregabalin | 87 | 2,912 | $2,096.97 | 30 |
| Hydrochlorothiazide | Hydrochlorothiazide | 78 | 6,180 | $405.11 | 30 |
| Clonazepam | Clonazepam | 76 | 2,226 | $607.14 | 16 |
| Metoprolol Succinate | Metoprolol Succinate | 76 | 5,889 | $747.70 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 73 | 5,610 | $761.23 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 72 | 6,490 | $1,134.76 | 33 |
| Zolpidem Tartrate | Zolpidem Tartrate | 67 | 2,250 | $445.60 | 14 |
| Furosemide | Furosemide | 66 | 5,462 | $236.09 | 24 |
| Ozempic | Semaglutide | 63 | 2,164 | $71,983.66 | 20 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 62 | 4,344 | $839.33 | 24 |
| Metformin Hcl | Metformin Hcl | 62 | 5,410 | $241.27 | 29 |
| Lorazepam | Lorazepam | 59 | 1,951 | $291.15 | 13 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-09-24NUCC Taxonomy Code: 363LP2300X
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20211018001131
TX
1153729496
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Pallicare, Inc
5803 Stoneridge Dr, Texarkana, TX 755031461
Phone: 9032785747
Brookridge Internal Medicine Associates, Pa
300 N 3rd St, Longview, TX 756016505
Phone: 9033152907
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated September 24, 2021.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from October 2021 to August 2026.
NPI Administrative Meta
Other Nurse Practitioner - Primary Care Specialists in Longview
- Daytral Brown, NP
- Karey Barbee, NP
- Samuel Nemati, FNP
- Charlsie Gillcoat, ACNP-BC
- Stacy Bratcher, FNP-C
Mailing Address
300 N 3rd St
Longview, TX 756016505
Phone: 9033152907